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Abstract
Background and Objectives:  The process of formulating in the area of dementia care is at an 
early stage of development.  A review published in 2016, identified 14 different types of 
formulation-based approaches for the management of Behavioural and Psychological 
Symptoms of Dementia (BPSD).   The present study examines professionals’ views about the 
use of systematic formulations for choosing first-line non-pharmacological interventions for 
BPSD. 
Methods: A 34-item online survey, with six items about formulation-based interventions for 
the management of BPSD, was circulated to multi-disciplinary UK dementia networks. 
Quantitative data were examined for the use of formulation-based frameworks in practice. 
Thematic analyses provided insight into the practicalities of using formulations.
Results: The majority of the 355 participants responding to the questions stated they used 
formulation-led models to inform interventions, but 24% stated they did not. Thirty-two types 
of formulation frameworks were named, and there was a diverse spread across the UK.  The 
Newcastle model was the most frequently used framework, with fifty percent of the 
participants who formulated reporting using this framework.   Four themes regarding the use 
of formulation emerged, relating to function, process, reported outcomes and obstacles.  
Conclusion: Formulation-based approaches to targeting intervention are becoming popular in 
dementia care in the UK. More types of formulation frameworks are used in practice 
compared with the 2016 review.    The use of formulations are seen as key to offering an 
alternative to pharmacological treatments. Understanding both the value of formulation-led 
































































Current clinical guidance, including the updated NICE Dementia Guidelines (2018) referring 
to BPSD, recommend using non-pharmacological approaches as first-line interventions 
before resorting to antipsychotics and benzodiazapines.   Exceptions are made when there is a 
high level of risk requiring sedating or tranquilising, or when an underlying psychotic 
condition is evident.  In general, however, non-drug approaches are supposed to be trialled 
initially, alongside medications directed at treating any underlying medical conditions that 
may be sources of agitation (infection, pain, dehydration, thyroid problems, etc.).   The 
British Psychological Society’s recent briefing paper recommend the use of formulation-led 
interventions to aid in the detection and management of BPSD (James and Moniz-Cook, 
2018).   The Royal College of Psychiatrists (Summers et al. 2017) describe a formulation as 
an attempt to explain how a situation is developed, maintained or resolved, or is an attempt to 
make sense of what has happened.  The role of formulation has received a lot of attention of 
late, and many specialist organisations are committed to training all their clinicians in the use 
of formulation. In the UK the universal use of formulation-led strategies has been successful 
in many NHS specialisms (adult, child, forensic and learning disabilities), however, problems 
have arisen in the area of dementia care.  In part this is because dementia services cut across 
many non-mental health organisations (acute NHS care, private sector care homes, home-care 
providers, day centres, etc.) who are unfamiliar with the term and concept of formulations.  
Evidence, however, suggests that there is an emergent interest in the use of formulations in 
this area.  For example, Holle et al (2016) identified 14 examples of individualized 
formulation-led interventions for BPSD.  They examined each in terms of structural features 
and protocols, concluding that the impacts on people with dementia were mixed; half of the 
frameworks showed significant effects in terms of reductions in BPSD.   To understand the 
current use of formulations in the UK we undertook a survey, examining the views and 
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experiences of a diverse multidisciplinary group of clinicians regarding formulation-led 
approaches for the management of BPSD. 
Method
A multidisciplinary online survey was developed from the views of professionals working in 
the field of dementia care in the UK.  The perspectives were obtained during a one-day 
consultation workshop organised by the British Psychological Society to review NICE 
guidelines and examine practice associated with BPSD.  This was attended by 74 
professionals from a range of professions including psychology (50%), nursing (14%), 
psychiatry (8%), occupational therapy (OT, 8%), and other professions e.g. General 
Practitioner, pharmacy, physiotherapy; care practitioners, social work, family carers, NHS 
England employees and those employed by dementia charities (between 1 and 3 participants 
each).  Participants were recruited via email from a network of clinical psychologists who 
worked in services that provided care for people with dementia and from key professional 
organisations (e.g. Royal Colleges of Psychiatry, GP, Nursing and Occupational Therapy), 
third sector representation and family carers. 
From the consultation event (see James Moniz-Cook and Duffy 2019) a 34-item item 
questionnaire was developed on the topic of BPSD. The resulting survey was composed of 
seven sections (Name of concept; Use of management strategies; Knowledge of guidelines; 
Use of formulations; Training and supervision; Value of specialist teams; Value of existing 
guidelines).  All professionals attending the consultation event, and who consented to be 
contacted, were sent the online survey.  Additional professionals were contacted if they were 
known by the authors to have a specific interest in the topic; for example from medicine 
(Geriatricians/ GPs/ Neurology), nursing, speech therapy, social work and experts who had 






























































published in peer review journals.  A cascading snowballing method for recruitment was 
used.
From the 34-items, six questions related specifically to formulation:  Do you use 
formulations? (Y/N); How often? (likert scale); Who undertakes and who contributes to 
formulations? (both questions used drop-down choice of professions, plus free text); If you 
don’t use formulations, what approaches/strategies do you use to develop your care plans and 
interventions? (free text option).  Which formulation-led framework is most used for BPSD 
in your setting? (free text).  The latter question was used to identify specific models, which 
are presented in Table 2.  
Data Analysis
The qualitative data were analysed using the framework analysis method described by Gale et 
al. (2013). Author MM generated initial codes for 30 of the statements and derived a coding 
template.  IJ then applied the template to the statements.   After this process, the framework 
was amended and applied to a second set of statements in which rating agreement between 
MM and IJ reached 85%.   After this iteration, a final template was developed and MM then 
coded all of the remaining statements.
Ethics
The project was approved by the University of Hull Faculty of Health Sciences Ethics 
committee.
Results 






























































Responses from 378 participants in total were collected.  Over a third (38.6%) of the overall 
participants were nurses, with psychologists being the next most frequent contributors 
(22.2%), followed by psychiatrists and occupational therapists (see Table 1). Twenty two 
(5.8%) of the 378 participants registering on the survey did not provide any responses on the 
topic of formulation.  Of those providing a response (N=356), 273 (76.7%) participants stated 
they used formulations and 82 (23.0%) reported not using formulation frameworks (Table 1).  
One hundred and three (37.5%) of the total number of participants stating ‘yes’ to using 
formulations were nurses, and thus their views are well represented in the survey.  In all 
professional groups, except for GPs, the numbers of participants stating they used 
formulations were higher than the numbers of participants who did not.
Table 1: Survey of participants and numbers using formulations (column %)
Table 2 provides details of the formulation models named by the participants in relation to 
geographical regions.  The names of any models mentioned three or less times (<3) in total 
have not been represented in the table, however, details are presented at the foot of the table. 
There was good regional representation from across the UK.  Table 2 provides the number of 
participants from each region in the survey, and additionally lists the models used by the 273 
participants who stated they used a formulation.  Almost a quarter (24.2%, n=66) of those 
stating they used a model failed to provide a ‘named’ example.   Two hundred and seven 
respondents outlined a total of 31 ‘named’ frameworks for resolving BPSD (Table 2).  The 
greatest number of participants came from the Yorkshire region, although they were the least 
likely to use formulations (60.5%).  Participants from Scotland were the most likely to use a 
specific formulation, with 95% of the Scots providing a named approach.






























































One hundred and thirty nine (67.1%) participants stated they used only one model, the 
remaining third of the participants in this group used several models, ranging from two to 
four types.  This may reflect the need for adaptations across work settings and also that the 
service-users displaying BPSD are a diverse population.  Approximately 50%  (49.8%) of the 
respondents stating they used a formulation reported using the Newcastle model (James, 
1999, 2011) and 21.6% employed Kitwood’s flower of need (Kitwood, 1997).  These were 
also the only two models used across all regions.  Table 2 shows there was regional variation 
of formulation usage, with particular models being preferred in specific areas.  For example, 
the CLEAR model (Duffy, 2015) is the preferred model in Northern Ireland, where it was 
developed.
Table 2: Overview of participants’ use of the nine most favoured formulation models across 
the regions of the UK
Of those who indicated they used formulations, 37.5% used them with ‘almost everyone’ 
(n=104) and 30.2% used them ‘often’ (n=83); 3.3% of participants used them rarely (n=9).  
Twenty-nine respondents did not provide a frequency score (10.5%).  Eighty-four percent 
rated the use of formulations as either ‘extremely useful (n=131)’ or ‘very useful’ (n=74); 
12.3% stated they were ‘moderately useful’ (n=30).  Less than 3% rated formulations as 
either slightly or ‘not’ useful (n=7).  This is from a total of 244 respondents who answered 
this question on usefulness.
In relation to ‘who contributed to the development of the formulations’, the formulations 
were produced with the assistance of a diverse range of professional groups.  Of the 242 
responses to this question nurses were seen as the greatest contributors to the development of 






























































formulations, involved in (87.6%/ n=212) of the cases. Followed by family members 
(77.3%/n=187), psychologists (75.2%/n=182), occupational therapists (OT, 65.7%/n=159), 
care home staff (57.9%/n=140) and psychiatrists (55.4%/n=134).  However, the writing-up of 
the formulations (n=238) was chiefly the preserve of psychologists (70.6%/n=168) and 
nurses (58.4%/n=139), with the only other major contributors being OTs (30.0%/n=69).  
Psychiatrists were involved in the write-up on 7.9% (n=19) of occasions.
Participants worked across different areas, including community, inpatient acute, inpatient 
mental health, care home settings, and other (Hospices, Memory clinic, GP clinic, 
Universities, Dementia organisations, retired etc. n=87).  Forty-one percent of staff who 
answered questions on formulation worked across multiple areas, with 146 (40.9%) clinicians 
working across two or more clinical settings.   One hundred and ninety-seven (55.2%) 
clinicians worked in community/own home settings as either part or all of their roles; 120 
(33.6%) worked in inpatient mental health as either part or all; 118 (33.1%) worked in care 
homes as either part or all; 53 (15.4%) worked in inpatient acute as either part or all of their 
role.  In order to obtain insight of which formulations models were used in specific clinical 
areas, we examined the use of models for those people who worked in only one setting – see 
Table 3.  Table 3 presents the results of the six most frequently used models.  The findings 
show that the Newcastle model is the most frequently used model across all settings, although 
there is no real difference in acute inpatient settings.  Here, 15 of 27 respondents stated they 
used a formulation while 12 said they did not.  The greatest range of models occurred in the 
community setting.
Table 3: Profile of the six most frequently used models employed by participants who 
worked exclusively in one specific setting






























































A thematic analysis was conducted with the qualitative responses of the participants who 
stated they used formulation. Four themes emerged from this process: (1) Function, (2) 
Process, (3) Reported Outcomes, (4) Obstacles. 
1. Function
Formulations help to address unmet needs and highlight the service users’ difficulties (Algase 
et al. 1996). Additionally, formulations were seen to function as a method to increase 
knowledge of the person. Numerous responses suggested that formulations increase the 
awareness of the life of the person with dementia by “allowing everyone in the room to see 
the person and not just the behaviour.” The participants noted that formulations increase 
feelings of empathy toward the person from care staff as well as family members. 
Formulation enables “a person centred – rather than problem centred – approach”.  It was 
also noted that one of the functions of formulation was to establish personalised interventions 
that can be used to develop meaningful activities and effective clinical strategies for the 
person with dementia.  
2. Process
The process of using formulations was to enable staff to understand the person with dementia 
better. For example, the following response highlights how ‘team’ formulations were seen to 
be beneficial:
“Weekly team formulations are used on the wards to help staff understand, get to 
know and work with individual patients. It enables us all to be working from the same 
information and allows us to implement interventions in a uniform, consistent way.”






























































Participants suggested that staff valued the collaborative nature of formulating because the 
process was inclusive and explored perspectives from all individuals – staff and/or family 
members – working with the person. The joint effort enables people involved in the care to 
“have a voice” and create a shared plan. Finally, the process of developing a clear, structured, 
and easily updateable structural framework was seen to be beneficial. The collaborative 
process meant that the information needed to be understandable to all involved and also 
written in a clear and concise manner. 
3. Reported Outcomes
There was a consensus that formulations were helpful and they directly influenced successful 
outcomes. For example, the following response describes this:
“A detailed, informed formulation leads to more reliable hypotheses regarding unmet 
needs; and then intervention plans can be tailored in order to meet these needs. This is 
much more helpful than using a trial and error approach. A well-developed/well-
implemented formulation led intervention plan leads to better outcomes for people 
with dementia and services.”
A less focused ’trial and error’ approach was perceived to lead to poorer outcomes because it 
did not involve an understanding of the person, their life history, and their unmet needs. 
Many respondents reflected on how using a helpful formulation reduced the need for using 
psychotropic medication. 
4. Obstacles
Staff reported practical constraints about formulation, i.e. time constraints, staff shortages, 
larger caseloads, and extra paperwork associated with the frameworks.  One participant said 
that formulation were not routinely used because the medical model was the principal 






























































approach on their unit:  “Formulation use varies because our service follows a medically 
dominated model and there’s a resistance to working in other ways.”
Additionally, it was noted that some services lacked the appropriate training and support to 
facilitate formulation sessions.  On a different, but related problem, it was acknowledged that 
the degree of helpfulness of a formulation depended on whether the care staff implemented 
the strategies suggested by the framework; which was not always the case.  Thus, participants 
stated that ‘if’ staff neither supported nor implemented the formulation-led strategies the use 
of such frameworks became a ‘paper exercise.’
Participants not using formulations
The 82 participants who stated that they did not formulate were asked to indicate what 
alternative strategies they used with BPSD.   The alternatives are outlined in Table 4.   In 
many situations the ‘alternatives’ are actually versions of a formulation (see Table 4, section 
A).  The participants appeared reluctant to call them a ‘formulation’ because of their brevity 
and/or the lack of comprehensiveness compared to that of established structural frameworks.  
Nevertheless, the models they employed appear to conform to the description of a 
formulation given in the introduction. 
In section B of Table 4 we see that some participants suggested that either ‘care plans’ and/or 
‘clinical meetings’ were suitable alternatives to formulations.  It would be interesting to 
determine the process/structure of both the care plans and meetings.  For example, if they 
followed a protocol or a bespoke structure in a formulaic manner, the plans and meetings start 
to look like a type of formulation.  This point is well illustrated in the following quote:
“We do not use formal formulations but in a way we use the approach.  We are 
developing a system of traffic light support plans for each individual resident to 
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reflect what they enjoy linked to past and current preferences to include activities, 
environment, and social interactions and how these may be used to support well-being 
or reducing distress.”
Section C provides examples of practical alternatives to formulation, focusing on the ‘here 
and now’ interactions rather than background details of people with dementia.   It has been 
argued by Carter (1976) that this approach is how many nurses, in particular, learn their 
clinical skills.  This is a non-strategic approach to nursing care in which staff become skilful 
through experience and ‘doing’, and via observation of colleagues.
Table 4: Alternatives to formulations by participants who stated they did not use 
formulations
Discussion
The present study used an on-line questionnaire to garner participants’ views and 
perspectives toward formulation. It was shown that more participants used formulations 
compared to those who reported ‘not using’ them.  The sample had a good representation 
across region and disciplines. The most frequently used frameworks were the Newcastle 
model, Kitwood model, and a variety of biopsychosocial conceptualisations.  Table 2 
provides a good overview of the sample by region and model usage and, while a relatively 
small number of frameworks dominated, over thirty (n=31) different models were mentioned 
in the survey.   This high number does raise one concern because it may reflect a lack of 
clarity in the participants’ views about the nature of formulations.  Indeed, while this survey 
was specifically aimed at identifying models, it is possible that some of the participants were 
replying in terms of philosophies rather than specific frameworks.  For example, Kitwood’s 






























































work can be viewed in terms of either a person-centred methodology or a conceptualising 
framework (eg. the flower of needs model).  We accept this as a potential weakness, but at 
the planning stage of the survey we agreed to accept any response within the category of a 
framework in which both a published framework existed and was known to be being 
employed clinically.  Nevertheless we are mindful of the issue and it is an important potential 
confound to highlight.
Table 3 presents the results of the six most frequently used models for those participants who 
only worked in one setting; this analysis gave us a clearer idea of the association between 
clinical setting and model.  The findings showed that the Newcastle model is the most 
frequently used framework across all settings, although there was no real difference in acute 
inpatient settings.  Here, 52% of respondents stated they used a formulation, but only 36%  
were able to name a specific model.   This suggests that in acute settings formulations are not 
as well established compared to other settings.  The greatest range of models occurred in the 
community setting which could be accounted for by there being a less standardised approach 
to working with families of various sizes and compositions.  This could be contrasted to a 
ward or care home services, where the organisation or care provider might adopt a specific 
approach which all the team members would need to adhere to.  Thus in the community there 
may be more scope for individual clinicians to choose which ever model they prefer; hence 
the greater variety.
Approximately 11% of staff using formulation frameworks reported not knowing the names 
of the models they used. Whether participants were unaware of the models they were using 
or, alternatively, they used generic models, was unclear. Four themes emerged from 
responses to the open-ended questions: (1) Function, (2) Process, (3) Reported Outcomes, 
and (4) Obstacles. Formulation was viewed as a useful and helpful method in clinical 
settings. This was evidenced by three of the four emergent themes reporting positive 






























































attributes of formulation. For instance, the first theme – Function – included views that 
formulation benefitted care by increasing knowledge of the person by understanding their life 
story. Formulation was seen to raise awareness of the person’s difficulties through an 
empathic manner. The Process theme illustrates that staff acknowledge that formulation is an 
inclusive process that values perspectives from everyone involved across disciplines. The 
Reported Outcomes theme suggested that use of formulations led to successful interventions, 
effective care planning, and reductions in the use of psychotropic medications.  The above 
findings are generally consistent with the RCPsych paper entitled ‘Using formulation in 
general psychiatric care: good practice’ extoled the virtues and various functions and 
processes involved in the use of formulations (RCPsych Occasional Paper 103, 2017).  
Similarly, in a qualitative study undertaken with psychiatrists, Mohtashemi et al (2016) 
suggested that formulations should be seen as important additions to diagnoses, and used in 
cases of risk and complexity.  They found that psychiatrists valued formulations, particularly 
when they had support from experienced formulators in the development of the conceptual 
models.  They produced a dynamic diagrammatic model explaining the benefits and obstacles 
of using formulations.  The pros included: achieving a greater understanding of patients’ 
needs, triggers and risks; improved team working; and coproduction.  Consistent with the 
present study, the following cons were mentioned: time restraints; training deficits; and 
pressure and disagreements.  
In considering the perceived Obstacles to formulation, concerns related to practical 
constraints. For instance, staff shortages and time constraints as difficulties in undertaking 
formulations.  To address this concern the “Mental Health and New Models of Care” 
document emphasises the importance of upskilling staff to improve their pressured working 
conditions (Kings Fund, 2017). 
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Responses in our survey suggest that knowledge of the formulation process benefits from 
frequent team formulations sessions or multi-disciplinary team (MDT) case-discussions. Such 
meetings were reported to enhance knowledge both of the person as well as the formulating 
process. Despite the quantitative data indicating nurses were undertaking formulations 
frequently, the notion that formulations are ‘largely the domain of psychologists’ persists.  
This is in contrast with the evidence that non-psychologists (i) were involved in developing 
them, and (ii) were ‘formulating’ without using this specific term. Indeed, when respondents 
in the latter group were asked what alternative tools they used in place of formulations, many 
of their substitutions resembled formulations (Table 4).  Examples included obtaining a 
clinical history, discussing the case with the family, having MDT meetings, assessing 
communication and interactions skills, using clinical reasoning, etc. 
The results in the present survey showed that participants were using formulating methods to 
explain a person’s presentation, though not necessarily using the term ‘formulation’ or 
‘formulating’ to describe their approaches.   This finding is consistent with Reichelt’s paper 
(Reichelt, Moody, Wells & James, 2019) that argued that many clinical staff harbour the 
misconception that unless they are using an established conceptual framework (eg.  
Newcastle model, Kitwood, a Biopsychosocial Model, see Holle et al, 2016), they are not 
formulating.  In order to clarify this issue, let us look at the differing functions of 
formulations and formulating.  
Formulation frameworks provide individualised templates from which to produce care plans 
and facilitate the actions to be undertaken by staff.  The framework is the product of 
information gathering and assessment, and typically contains information about current 
behaviour, type of dementia/cognition, history, prior personality and health status (Holle et al. 
2016).  This information is helpful in producing targeted interventions, but has limitations as 






























































useful, the component information needs to be integrated and features prioritised, using a 
problem-solving process.  For example, background (distal) features can be linked to ‘here 
and now’ behaviours and emotions (proximal) as illustrated in the Newcastle model.  The 
integrated details can be used to produce a hypothesis, care plan and targeted management 
strategies.
Table 2 provides a list of the names of formulations provided by the participants.  It is 
relevant to note that the formulations are not completely discrete frameworks, with some 
sharing similar origins.  This is well illustrated with the presence of a number of person-
centred approaches (VIP and DCM), which have their origins in the work of Kitwood,  
However, it is relevant to note that Kitwood produced his own specific framework (i.e. The 
Flower of Need, Kitwood 1997) which many clinicians use as a conceptual model.  This level 
of distinction between person-centred frameworks and philosophy was highlighted in the 
one-day workshop we described in the method section, and this is why we have not combined 
all the person-centred models under one category.  A similar situation occurred with a 
number of the models that were based on ‘meeting people’s needs’.  While both Cohen-
Mansfield and Maslow (1957) have frameworks based on ‘unmet needs’, both are distinctive 
frameworks and therefore were not combined within a single category.  Indeed, Cohen-
Mansfield’s (2000) framework, composed of background and behavioural elements, has been 
shown in this survey to be one of the most widely used models across UK.
In contrast to the structural formulation frameworks, the process elements are the features 
concerned with the manner in which the relevant data are collected and used.  The process 
features are not concerned with ‘what’ information should be collected, but rather ‘how best 
to collect it’.   For example, via the use of questioning, education, and collaborating with 
other team members.  For this reason the process features actually drive the awareness, 
involvement and subsequent understanding of staff, increasing the likelihood they will 






























































implement the interventions produced from the frameworks.  To optimise the benefits of 
good formulation processes, we have made the following recommendations based on both 
our discussions from the one-off consultation workshop (linked to the development of the 
survey), and a programme of work on the use of formulations conducted over a number of 
years (James, 2011; James and Jackman, 2017).
The formulating process needs to:
 be done over a period of time in order to allow the staff to assimilate, adjust and
become stakeholders in the process
 give staff an understanding about why they need to interact or do something
differently with the person with dementia
 aim to motivate the staff to do things differently (promote empathy)
 translate into clear behavioural goals (a simple sensible care plan)
 be comprehensive enough to do all the above, but not so complex that it’s confusing
If we accept these process features are relevant, we can see why it is important that no one 
person (or profession) within a clinical service is left solely to produce the framework.  
Indeed, if a framework (no matter how comprehensive) suddenly appears within a treatment 
programme, it is less likely to motivate and inspire changes in people’s clinical practices, 
compared to a framework that has been coproduced.  It is relevant to note the limitations of 
the survey prevented us making any relevant conclusions about the relationship between the 
use of formulations and non-pharmacological interventions as alternatives to psychotropics 
for BPSD as recommended in the NICE guidelines.  This is an issue that requires future 
investigation.
Prior to examining the limitations of the study, it is worth noting the influences of some 
potential organisational biases in relation to model selection.  Indeed, the selection of which 
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formulations to choose is not always the personal choice of a clinician, but may reflect the 
management plans of either organisations or regional training programmes.   There are at 
least two examples of such biases in our survey.  The first example is seen in the high 
percentage of use of the CLEAR model in Northern Ireland (Table 2).  The usage is 
explained by the fact that CLEAR was developed locally and has been part of a 
comprehensive training programme over the last five years in Northern Ireland.  Example two 
is reflected in the high level of use of the Newcastle model in Scotland (Table 2).  The 
Newcastle model was incorporated within NHS Education Scotland’s national dementia 
training programme, owing to it being one of the few models included in an evidence-based 
training manual (Fossey and James, 2007).
In terms of the limitation of the study, firstly, it is relevant to consider the method of 
recruitment to the project.  The selection involved a prior workshop/meeting and then the 
targeting of participants who were known to have an interest in the field. While the method 
enabled us to sample a large population, it probably gave us a more positive perspective on 
formulation than currently exists in a general population of clinicians.  Secondly, 94.2% of 
those registering on the survey answered questions on formulations, and so it is not clear why 
some respondents did not complete this section.  Thirdly, the self-report methodology used 
may have contributed to a response bias.  Further since an online questionnaire was used the 
group was self-selecting and thus the results reflect a people with a particular interest in 
BPSD. Though there was a heterogeneous sample, with staff from multiple disciplines, a 
greater number of nurses and psychologists participated in the survey compared to other staff 
members. This may have skewed the responses provided.   As also may have been the case 
with some regional biases, with high levels of representation from the Yorkshire region.  
However, a strength of the methodology was its openness for participation from a wide range 






























































the mixed methods approach which generated quantitative and qualitative data, helping to 
clarify a number of perspectives.  
Conclusion 
Amongst our self-selecting participants formulation-use was common, across regions, 
professions and clinical settings.  The results of this survey has provided a good overview of 
the use of formulations in the UK, and has provided evidence that a large, perhaps increasing, 
range of formulations are being used.  The more established formulations were used more 
frequently, such as the Newcastle, Kitwood and biopsychosocial models.  Although still seen 
as the domain of psychologists by some, many different professional groups are involved in 
the development of formulation, which is a positive development.
The qualitative themes showed that formulations were generally seen as beneficial and 
considered to lead to positive outcomes in BPSD. The potential obstacles related to the 
system constraints and practical concerns (i.e. staff shortages, lack of resources, time 
constraints) rather than any negative perspectives of formulation as an actual method.  When 
the 82 participants not using formulations were asked to provide alternatives to the approach, 
many of these substitutes resembled definitions of formulations (i.e. taking a clinical history, 
discussing with family, and assessing communication skills).  This suggests that clinicians 
were using problem-solving strategies, similar to formulations ‘in all but name’ without 
recognising they were doing so.  Staff should be encouraged, and made aware, that they may 
still be formulating, and have the skills to do so. 
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 Table 1: Survey of participants and numbers using/not using formulations (column %)
Occupation   Respondent 
registered in 
survey
Said ‘Yes’ to 
using 
formulations
Said ‘No’ to 
using 
formulations





103 (37.5% of 
participants saying 
‘yes’ were nurses)
30 (36.6% of 
participants saying 
‘no’ were nurses
Clinical Psychologists 84 (22.2%) 80 (29.1%) 2 (2.4%)
Psychiatrists 38 (10.1%) 30 (10.9%) 6 (7.3%)
Occupational Therapists 25 (6.6%) 20 (7.3%) 5 (6.1%)
General Practitioners 7 (<1%) 2 (<1%) 5 (6.1%)
Social Workers 6 (<1%) 0 1 (1.2%)




researchers, third sector, 
neurologist, home care 
workers)
69 (18.3%) 36 (13.8%) 32 (39.0%)
TOTALS 378 273 82






























































Table 3: Profile of the six most frequently used models employed by participants who worked 
exclusively in one specific setting
*The figures do not add up exactly due to some participants stating they used formulation and then








inpatient Care home Other
Newcastle 19 23 3 9 22
Cohen 
Mansfield 3 2 2 2 4
Functional 
analysis 1 1 2 1 1
CLEAR 0 4 1 3 2
Kitwood flower 
need 14 4 0 0 11
Biopsychosocial 9 4 1 1 1
Said ‘No’ to using 
formulations 22 4 12 2 20
Said ‘Yes’ to using 
formulations 54 43 13 13 38
‘Yes’, but not state 
name of formul’n* 8 6 4 0 0






























































Table 4: Alternatives to formulations by participants who stated they did not use formulations
A. Alternative Conceptual Models (Proxy formulations)
 “Clinical history. Discussion with family. Understanding the past. Review of
behavioural chart. Discussion with staff.” (Psychiatrist)
 “Take a thorough personal history and social history; review previous contact with
mental health services; physical health history, recent tests and examinations,
medications current and past, issues which could be contributing e.g. pain; description
of the problem/s e.g. duration, frequency, severity, symptoms, triggers; review any
notes e.g. daily care records, ABC charts; liaise with relatives and carers for their
perspective; cognitive testing if appropriate; observation periods.” (Nurse)
 “I take a history and examine, get a collateral history.  In general practice we only
have 10 mins - so I don't have time to do a proper psychiatric formulation. However, I
do use all the data to inform a differential list of why a PwD may be behaving that way
- are they in pain etc., have they not had their regular pain relief, is there an infection,
etc.” (General Practitioner, GP).
B. Care Plans and Meetings as Alternatives
 “Care planning, formal assessment, MDT meetings.” (GP)
 “Multi-disciplinary assessments and care planning.” (Nurse)
 “Through initial and ongoing assessment where knowledge is gained about the person
that is then used to create care plans that reflect personal history, preferences, likes and
dislikes.” (Occupational therapist, OT)
 “Psych team input.” (Nurse)
 “Multi-disciplinary team assessment – OT and nursing.” (OT)






























































C. Communication and Interaction Skills
 “Assess the person with dementia's communication skills and interactions and how
these impact on behaviour, assess the communication of the people around the person
with dementia and how this impacts, provide education and advice and strategies to
those around the person, one to one input if able.” (Speech & Language Therapist)
 “I look and learn from the people I work with and alter my behaviour and interactions
accordingly.” (Member of Alzheimer Society)
D. Other Miscellaneous Responses
 “We ask the individual and the people who know them best.” (GP)
 “History and examination. May use ABC. Time pressured services and clinical
assessment pre-empts use of lengthy assessment tools.” (Psychiatrist)
 “Trial and error.” (Dementia Researcher)
 “Often it is hit and miss; sometimes an attempt is made at attempting a patient’s life
story and speaking to family to try and understand certain behaviours.” (Nurse)
 “Clinical reasoning.” (OT)
 “Empirical.” (Psychiatrist)
 “Based in Accident & Emergency so information collected largely dependent on time
of day and staff involved, currently working to improve care that this group of
vulnerable patients receive.” (Nurse)
 “I am aware of formulations, but do not use this as I’m a researcher.” (Researcher)






























































Responses to: Which formulation-led framework is most used for BPSD in your setting?
Number saying 





















16 5 7 5 0 4 4 0 0 22
Midlands
N=30/47 (63.8%)*
12 12 5 1 0 1 2 2 0 9
Scotland
N=38/40 (95.0%)*
37 8 4 5 0 6 0 1 0 0
N. East England
N=29/37 (78.4%)*
19 6 2 1 0 2 1 0 4 4
South England & 
Chan. Isles
N=26/38 (68.4%)*
15 12 3 3 1 2 0 0 0 4
NW England.
N=25/33 (75.8%)*
12 7 1 0 0 1 0 2 0 6
London area
N=27/32 (84.4%)*
9 2 4 2 1 1 0 0 0 12
Northern Ireland
N=23/27 (85.2%)*
2 2 0 2 17 0 0 0 0 4
Wales
N=14/21 (66.7%)*
8 2 2 1 1 1 0 0 0 4
Cumbria & Lancs
N=9/12 (75.0%)*
6 3 0 0 0 0 0 1 0 1
136 59 28 20 20 18 7 6 4 66**






























































*Percentage of participants from a region who stated that they used a formulation.
** 66 (24.1%) of those stating they used a formulation ‘did not/were unable’ to specify a ‘named’ model.
*** Four participants did not state the region in which they worked.
Other models mentioned:
Dementia Care Mapping; Teepa Snow/PCA; Positive Behavioural Support (N=3 respondents used this model)
Tees Esk & Wear model; Systemic; DICE; Brooker/VIP (N=2)
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